UAS Asset Management’s Pfizer PFE Stock Holding History

UAS Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,301	Closed	-$528K	–	25
2022 Q4	$528K	Buy	10,301 +5,301	+106%	+$254K	0.19%	19
2022 Q3	$219K	Buy	+5,000	New	+$243K	0.07%	12
2017 Q1	–	Sell	-109,959	Closed	-$3.39M	–	30
2016 Q4	$3.39M	Sell	109,959 -33,622	-23%	-$1.03M	2.01%	15
2016 Q3	$4.61M	Sell	143,581 -6,061	-4%	-$203K	3.17%	10
2016 Q2	$5M	Buy	149,642 +11,515	+8%	+$368K	2.9%	12
2016 Q1	$3.88M	Buy	+138,127	New	+$3.95M	2.29%	13
2013 Q3	–	Sell	-21,080	Closed	-$560K	–	32
2013 Q2	$560K	Buy	+21,080	New	+$582K	0.39%	25

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UAS Asset Management's PFE Position: Q1 2023 in Review

UAS Asset Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 10,301 shares — an estimated $528K sold.

UAS Asset Management first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $5M in Q2 2016. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

UAS Asset Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
UAS Asset Management sold 10,301 Pfizer shares in Q1 2023, an estimated $528K.
UAS Asset Management first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
UAS Asset Management's Pfizer position peaked at $5M in Q2 2016.
3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on UAS Asset Management's 13F filing for Q1 2023, filed 15 May 2023.